Results

Total Results: 1,249 records

Showing results for "developed".

261. Evidence Summary: Anxiety Disorders in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/anxiety-adults-screening
     June 20, 2023 - Figure 1 shows the analytic framework and key questions (KQs) that guided the review, which were developed … A decision tool developed by Pollock et al 9 was adapted to identify the most current and comprehensive … results between studies, precision of findings, and limitations of the body of evidence, using methods developed … Fourth, the review was limited to studies conducted in highly developed countries and has limited generalizability

262. Archived: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis-june-2019
     June 11, 2019 - When developed and validated, risk assessment instruments should include those populations most at risk … Effectiveness of Risk Assessment The USPSTF found 7 studies that evaluated risk assessment tools developed … Some instruments were not validated in independent cohorts, and several instruments were developed and … Most of the studies of risk prediction tools in men who have sex with men were developed in predominantly

263. Testimony for the House Energy and Commerce Health Subcommittee Hearing (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/tfcongresstestimony%20(3).pdf
     November 30, 2016 - Since its inception, the USPSTF has developed recommendations to inform care and to be useful guides … This paragraph was developed in consultation with Dr.

264. Archived: Gestational Diabetes Mellitus: Screening, 2003 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/gestational-diabetes-mellitus-screening-2003
     February 01, 2003 - Diagnostic criteria in the United States are based on a 100‐g 3‐h OGTT, but these criteria were originally developed

265. Archived: Final Research Plan: Child Maltreatment: Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/child-maltreatment-primary-care-interventions-november-2018
     August 18, 2016 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Research Plan Child Maltreatment: Interventions August 18, 2016 Recommendations made by the USPSTF are independent of the U.S. government. They should not b…

266. USPSTF: An Overview (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/uspstf-overview-fact-sheet-2021.pdf
     January 01, 2021 - USPSTF: An Overview • • • USPSTF: An Overview The U.S. Preventive Services Task Force (USPSTF or Task Force) works to improve the health of people nationwide by making evidence-based recommendations on effective ways to prevent disease and prolong life. Through this work, the Task Force helps healthcare provi…

267. USPSTF: An Overview (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/uspstf-overview-fact-sheet-2021_0.pdf
     January 01, 2021 - USPSTF: An Overview • • • USPSTF: An Overview The U.S. Preventive Services Task Force (USPSTF or Task Force) works to improve the health of people nationwide by making evidence-based recommendations on effective ways to prevent disease and prolong life. Through this work, the Task Force helps healthcare provi…

268. Final Research Plan: Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cardiovascular-disease-screening-using-nontraditional-risk-assessment
     September 03, 2015 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Research Plan Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors September 03, 2015 Recommendations made by the USPSTF are independent of the U.S. g…

269. Primary Care–Relevant Interventions to Prevent Opioid Use Disorder: Current Research and Evidence Gaps (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/prevention-of-opioid-user-disorder-ehc-tech-brief.pdf
     May 14, 2021 - Most of these more intense interventions are similar continuing medical education programs—some developed … Risk Assessment Multiple risk assessment tools have been developed to help identify patients who … and Opioid Assessment for Patients with Pain-Revised [SOAPP- R], Opioid Risk Tool [ORT]) have been developed … Models have also been developed to predict the risk of respiratory depression or overdose among individuals … for acute pain indications, recommend indications for which new evidence-based guidelines should be developed

270. USPSTF and Expert Input (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2025-06/uspstf-expert-input-fact-sheet-2021_updated_2025.pdf
     January 01, 2025 - USPSTF and Expert Input www.uspreventiveservicestaskforce.org USPSTF and Expert Input Engaging with topic experts and specialists is an essential part of the Task Force’s process. The U.S. Preventive Services Task Force (USPSTF or Task Force) is a scientifically independent group of national experts in preven…

271. USPSTF and Expert Input (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2025-06/USPSTF-expert-input-fact-sheet-2025-update.pdf
     January 01, 2025 - USPSTF and Expert Input www.uspreventiveservicestaskforce.org USPSTF and Expert Input The U.S. Preventive Services Task Force (USPSTF or Task Force) is a scientifically independent group of national experts in prevention and evidence-based medicine that makes recommendations to primary care clinicians about pre…

272. Procedure Manual | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual
     December 01, 2015 - Procedure Manual Share to Facebook Share to X Share to WhatsApp Share to Email Print For the most up to date methods and procedures, please see https://www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes#methods .…

273. Draft Research Plan: Enhanced Risk Assessment for Cardiovascular Disease: Coronary Artery Calcium Scoring | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/cardiovascular-disease-enhanced-risk-assessment-non-traditional-risk-factors
     April 25, 2024 - Share to Facebook Share to X Share to WhatsApp Share to Email Print in progress Draft Research Plan Enhanced Risk Assessment for Cardiovascular Disease: Coronary Artery Calcium Scoring April 25, 2024 Recommendations made by the USPSTF are…

274. Screening for Speech and Language Delay in Preschool Children: Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ecWjjTgXCffjwPyqgNCEpR
     February 01, 2006 - Screening for Speech and Language Delay in Preschool Children: Recommendation Statement Screening for Speech and Language Delay in Preschool Children: Recommendation Statement U.S. Preventive Services Task Force The USPSTF concludes that the evidence is insufficient to recommend for or against routine use o…

275. Archived: Speech and Language Delay in Preschool Children: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/speech-and-language-delay-in-preschool-children-screening-2006
     February 15, 2006 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement Speech and Language Delay in Preschool Children: Screening February 15, 2006 Recommendations made by the USPSTF are independent o…

276. Carlos Roberto Jaén, M.D., Ph.D., M.S., FAAFP | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/current-members/carlos-roberto-jaen-md-phd-ms-faafp
     January 01, 2022 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Carlos Roberto Jaén, M.D., Ph.D., M.S., FAAFP Member Dr. Jaén, M.D., Ph.D., M.S., FAAFP, is a distinguished university professor, as well as a professor and chair emeritus …

277. Draft Research Plan: Breastfeeding: Primary Care Behavioral Counseling Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/breastfeeding-interventions
     March 10, 2022 - Share to Facebook Share to X Share to WhatsApp Share to Email Print in progress Draft Research Plan Breastfeeding: Primary Care Behavioral Counseling Interventions March 10, 2022 Recommendations made by the USPSTF are independent of the U.S…

278. Archived: Evidence Summary: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-latent-tuberculosis/latent-tuberculosis-infection-screening-september-2016
     September 06, 2016 - immunocompetent individuals with a positive TST result will develop active TB disease in their lifetime. 4 In developed … investigators assessed the quality of each study as good, fair, or poor, using predefined criteria developed … After 5 years, 1.4% of the placebo group and 0.5% of the 24-week treatment group developed active TB, … For this subset, active TB developed in 5 individuals in the combination-therapy group and 10 individuals … b Quality assessed using criteria developed by the US Preventive Services Task Force.

279. Evidence Summary: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction
     September 03, 2019 - Two investigators independently applied criteria developed by the USPSTF 12 to rate the quality of each … benign breast disease to the Breast Cancer Surveillance Consortium (BCSC) model. 37 A fourth new study developed … The NSABP P-1 trial of tamoxifen described results for 288 mutation carriers who developed breast cancer … first-degree or second-degree relatives with breast cancer (permits entry from age 40 years if both developed … atypical hyperplasia (permits entry from age 40 years); nulliparous and a first-degree relative who developed

280. Evidence Summary: Prevention of Dental Caries in Children Younger Than 5 Years: Screening and Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/prevention-of-dental-caries-in-children-younger-than-age-5-years-screening-and-interventions1
     December 07, 2021 - independent investigators assessed the quality of each study as good, fair, or poor using predefined criteria developed